ArnoldDLTaylorDJRaddaGK: Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol, 18: 189–196, 1985.
2.
ArnoldDL: Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg, 74: 447–435, 1991.
3.
BarbiroliB: A test object for quality control of 31P-MRS probes and localization techniques in a whole-body imager/spectrometer. Eurospin Quarterly, 27: 36–37, 1991.
4.
BarbiroliB: Muscle & Nerve, 15: 344–348, 1992.
5.
BarbiroliB: 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J Neurol Sci, 109: 188–195, 1992.
6.
BarbiroliB: Abnormal brain and muscle metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology, 42: 1209–1214, 1992.
7.
BarbiroliB: Spettroscopia RMN dell'encefalo. Rivista di Neuroradiologia, 5: 147–153, 1992.
8.
BarbiroliB: Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. J Neurol Sci, 119: 65–73, 1993.
9.
BarbiroliB: Defective Brain Energy Metabolism Shown by In Vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies. J Cerebral Blood Flow Metab, 13: 469–474, 1993.
10.
BryantDJ: Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin's lymphoma. J Comput Assist Tomgr, 12: 770–774, 1988.
11.
Cadoux-HudsonTAD: Human primary brain tumor metabolism in vivo: A phosphorus megnetic resonance study. Br J Cancer, 60: 430–436, 1989.
12.
CameronILSmithKR: The ionic regulation of cell reproduction in normal and tumor cells. Surv Synth Path Res, 2: 206–214, 1983.
13.
ChanceBWilliamsG: Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J Biol Chem, 217: 383–293, 1955.
14.
ChanceBEleffSLeighJSJr: Non-invasive, non-destructive approaches to cells bioenergetics. Proc Natl Acad Sci USA, 77: 7430–7434, 1980.
15.
De CertainesJDBoveeWMMJPodoF, (Eds): Pergamon Press, London1992.
16.
EleffSM: Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol, 27: 626–630, 1990.
17.
GlaholmJ: Tumor repopulatio during fractionated radiotherapy for breast carcinoma measured by in vivo 31-phosphorus magnetic resonance spectroscopy. 9th Annual Meeting of SMRM. Abstr 320, 1990.
18.
GuptaRKBenovicJLRoseZB: Magnetic resonance studies of the binding of ATP and Cations to human hemoglobin. J Biol Chem, 253: 6165–6171, 1978.
IottiS: Kinetics of post-exercise phosphate transport in human skeletal muscle. Biochem Biophys Res Commun, 176: 1204–1209, 1991.
21.
IottiS: The rate of phosphate transport during recovery from muscular exercise depends on cytosolic [H+]. A 31P-MR spectroscopy study in humans. Biochem Biophys Res Commun, 178: 871–877, 1991.
22.
MoolenaarWH: Regulation of cytoplasmic pH by Na+/H+ex-cahange. Trends Biochem Sci, 11: 141–143, 1986.
23.
NegendankW: Studies of Human Tumors by MRS: A Review. NMR Biomed, 5: 303–324, 1992.
24.
NiokaS: Relationship between intracellular pH and energy metabolism in dog brain as measured by 31P-NMR. J Appl Physiol, 62: 2094–2102, 1987.
PodoFOrrJS, (Eds): Istituto Superiore di Sanità, Roma1992.
27.
RossBD: Examination of a case of suspected McArdlès syndrome by 31P nuclear magnetic resonance. New England J Med, 304: 1338–1342, 1981.
28.
SmithSR: The assessment of treatment response in non-Hodggkin's lymphoma by image-guided 31P magnetic resonance spectroscopy. Br J Cancer, 61: 485–490, 1990.
29.
SuttonLN: J Neurosurg, 72: 65–70, 1990.
30.
StubbsM, (Guest Editor): Tumor assessment and Response to Therapy Studied by Magnetic Resonance Spectroscopy. NMR Biomed, 5 (5): 215–328, 1992.
31.
TaylorJS: Proc Natl Acad Sci USA, 88: 6810–6814, 1991.
32.
TwelvesCJ: A 31P MR spectroscopy study of breast cancer in vivo: Metabolite characteristics and infuence of estrogen receptor status and tumor grade. 9th Annual Meeting of SMRM Abstr 1216, 1990.
